Table 2
Univariate modelMultivariate model*
VariableOR (95% CI)p ValueOR (95% CI)p Value
Panel A: logistic regression analyses for modelling anaemia, haemoglobin (g/dl) <12 vs ≥12
HIV status, HIV+ vs HIV−3.84 (2.17 to 6.82)<0.001NA†
HIV+, CD4 >350 vs HIV−1.27 (0.59 to 2.75)0.541.47 (0.68 to 3.21)0.33
HIV+, CD4 200–350 vs HIV−3.09 (1.64 to 5.81)<0.0013.59 (1.88 to 6.83)<0.001
HIV+, CD4 <200 vs HIV−7.42 (4.05 to 13.58)<0.0018.09 (4.37 to 14.97)<0.001
Age (years), 30–40 vs <300.84 (0.54 to 1.31)0.44
Age (years), 40+ vs <300.65 (0.40 to 1.06)0.08
10–35 k Rwf vs <10 k0.67(0.46 to 0.98)0.040.68 (0.45 to 1.03)0.07
>35 k Rwf vs <10 k0.80 (0.47 to 1.38)0.430.94 (0.52 to 1.70)0.85
Some primary school0.96 (0.61 to 1.51)0.87
Secondary or university1.00 (0.65 to 1.56)0.98
BMI (per kg/m2) per unit0.87 (0.82 to 0.92)<0.0010.87 (0.82 to 0.93)<0.001
Alcohol 1–4 drinks/week0.97 (0.42 to 2.25)0.95
Alcohol >4 drinks/week1.09 (0.68 to 175)0.71
Co-trimoxazole or dapsone use2.45 (1.54 to 3.89)0.0002
WHO stage 4 illness, Yes vs No2.40 (1.68 to 3.43)<0.001
Widowed vs married/partner0.99 (0.67 to 1.47)0.96
Other vs married/partner1.29 (0.80 to 2.07)0.30
Smoking vs not smoking0.98 (0.33 to 2.92)0.98
Employed vs not employed1.07 (0.71 to 1.63)0.73
Panel B: logistic regression analyses for modelling neutropenia WBC (cells/mm3) <2000 vs ≥2000
HIV status, HIV+ vs HIV−9.68 (1.31 to 71.58)0.03NA†
HIV+, CD4 >350 vs HIV−2.51 (0.23 to 27.89)0.451.03 (0.08 to 13.15)0.98
HIV+, CD4 200–350 vs HIV−5.44 (0.68 to 45.51)0.121.86 (0.78 to 65.82)0.60
HIV+, CD4 <200 vs HIV−20.37 (2.71 to 153.1)0.0037.18 (0.78 to 65.82)0.08
Age (years), 30–40 vs <300.77 (0.33 to 1.77)0.54
Age (years), 40+ vs <300.28 (0.08 to 0.92)0.04
10–35 k Rwf vs <10 k1.07 (0.47 to 2.42)0.87
>35 k Rwf vs <10 k1.41 (0.48 to 4.14)0.53
Some primary school1.05 (0.39 to 2.80)0.92
Secondary or university1.20 (0.46 to 3.09)0.71
BMI (per kg/m2) per unit0.96 (0.86 to 1.06)0.40
Alcohol 1–4 drinks/week0.71 (0.09 to 5.43)0.74
Alcohol >4 drinks/week1.07 (0.40 to 2.89)0.89
WHO stage 4 illness yes vs no3.36 (1.57 to 7.21)0.002
Co-trimoxazole or dapsone use12.18 (1.65 to 90.0)0.0145.69 (0.63 to 52.5)0.12
Widowed vs married/partner1.15 (0.50 to 2.66)0.74
Other vs married/partner1.19 (0.43 to 3.34)0.74
Smoking vs not smoking1.28 (0.17 to 9.83)0.81
Employed vs not employed0.36 (0.11 to 1.22)0.10
Panel C: logistic regression analyses for thrombocytopenia, platelets (mm3) <125 vs ≥125
HIV status, HIV+ vs HIV−1.64 (0.96 to 2.80)0.07NA†
HIV+, CD4 >350 vs HIV−1.66 (0.87 to 3.16)0.132.18 (1.10 to 4.32)0.03
HIV+, CD4 200–350 vs HIV−1.81 (0.99 to 3.29)0.052.36 (1.25 to 4.45)0.008
HIV+, CD4 <200 vs HIV−1.47 (0.79 to 2.75)0.231.95 (1.01 to 3.79)0.05
Age (years), 30–40 vs <301.33 (0.74 to 2.37)0.341.29 (0.72 to 2.33)0.40
Age (years), 40+ vs <301.61 (0.88 to 2.95)0.122.32 (1.20 to 4.50)0.01
10–35 k Rwf vs <10 k0.89 (0.58 to 1.38)0.61
>35 k Rwf vs <10 k0.74 (0.38 to 1.45)0.38
Some primary school0.66 (0.40 to 1.11)0.12
Secondary or university0.77 (0.47 to 1.26)0.29
BMI (per kg/m2) per unit0.96 (0.90 to 1.01)0.120.95 (0.89 to 1.00)0.06
Alcohol 1–4 drinks/week0.17 (0.02 to 1.22)0.08
Alcohol >4 drinks/week0.87 (0.49 to 1.53)0.62
WHO stage 4 illness vs No0.78 (0.50 to 1.22)0.28
Co-trimoxazole or dapsone use1.10 (0.69 to 1.74)0.69
Widowed vs married/partner0.63 (0.40 to 0.98)0.040.49 (0.29 to 0.80)0.005
Other vs married/partner0.62 (0.34 to 1.10)0.100.59 (0.32 to 1.07)0.08
Smoking vs not smoking0.71 (0.16 to 3.09)0.65
Employed vs not employed1.15 (0.71 to 1.86)0.57
  • *By Stepwise selection with overall p=0.05 to enter and p=0.10 to remain for the entire variable. Only the variables selected into the final model are included.

  • †HIV+ status was fit into the multivariate model by CD4 category with HIV− as baseline.

  • BMI, body mass index; WBC, white blood cells.